Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Q-Med: medical device reports filed with FDA

1,051 reports name it as the manufacturer of the device involved, 2005–2026.

1,051
reports naming it as manufacturer
0% of all MAUDE reports
153
reports, 12 months to August 2026
109 in the 12 months before
0.5%
classified as malfunction
62.3% across all reports
0.1%
classified as death, as reported
0.9% across all reports

1,051 medical device reports received by FDA give Q-Med as the manufacturer of the device involved, 0% of the MAUDE database, from January 2005 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

153 reports arrived in the 12 months to August 2026, up 40% from 109 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (73%), other (25.1%) and malfunction (0.5%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
SculptraImplant, dermal, for aesthetic use204910%
Restylane Injectable GelImplant, dermal, for aesthetic use15700%
RestylaneImplant, dermal, for aesthetic use5360%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
LMHImplant, dermal, for aesthetic use93388.8%
LNMAgent, bulking, injectable for gastro-urology use878.3%
MOZAcid, hyaluronic, intraarticular323%

Reports by month, five years

01530Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 12022Jan 2022: 2Feb 2022: 15Mar 2022: 14Apr 2022: 10May 2022: 3Jun 2022: 14Jul 2022: 8Aug 2022: 14Sep 2022: 8Oct 2022: 1Nov 2022: 10Dec 2022: 282023Jan 2023: 11Feb 2023: 0Mar 2023: 17Apr 2023: 16May 2023: 11Jun 2023: 18Jul 2023: 13Aug 2023: 10Sep 2023: 7Oct 2023: 11Nov 2023: 11Dec 2023: 132024Jan 2024: 7Feb 2024: 7Mar 2024: 12Apr 2024: 17May 2024: 6Jun 2024: 7Jul 2024: 16Aug 2024: 4Sep 2024: 9Oct 2024: 12Nov 2024: 11Dec 2024: 152025Jan 2025: 2Feb 2025: 4Mar 2025: 7Apr 2025: 14May 2025: 5Jun 2025: 3Jul 2025: 13Aug 2025: 14Sep 2025: 10Oct 2025: 5Nov 2025: 5Dec 2025: 232026Jan 2026: 9Feb 2026: 5Mar 2026: 11Apr 2026: 14May 2026: 5Jun 2026: 15Jul 2026: 30Aug 2026: 21

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0.1%1
Injury73%767
Malfunction0.5%5
Other25.1%264
Not given1.3%14

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Q-Med reports

How many FDA device reports name Q-Med as manufacturer?

1,051 reports through August 2026, 153 of them in the latest 12 months.

Which of its brands appear most often?

Sculptra (204), Restylane Injectable Gel (157) and Restylane (53).

Which device types does it report on?

implant, dermal, for aesthetic use (88.8%), agent, bulking, injectable for gastro-urology use (8.3%) and acid, hyaluronic, intraarticular (3%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.